From Liston Street Pulse:
Enanta Pharmaceuticals, Inc. (ENTA) shares increased by 13.36% at $36.58, with total of 1,586,761 shares traded on Friday, Jan 31. This comes following the announcement of AbbVie on the positive result of the hepatitis C trial. AbbVie is the partner of Enanta Pharmaceuticals for the development of the said combo […]
The post Enanta Pharmaceuticals shares increased by 13.36% appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015